Financial Reports
Related Searches:
Filter by:
316 - 330 of 674 results
April 19, 2010
Total revenue in the U.S. was up 6% to $3.0 billion and outside the U.S. increased 13% to $2.5 billion.
Read More »
March 15, 2010
Revenues from commercial operations increased 9% to $128.1 million in the quarter, aided by currency fluctuations.
Read More »
February 25, 2010
In the quarter, income from operations was up 12% to $29.6 million and for the year was $116.3 million (+17%).
Read More »
February 18, 2010
Genetic Diseases revenue was $315.1 million in the quarter (-44%) due to product supply interruption.
Read More »
February 18, 2010
Revenue growth in the quarter was driven by strong Pharmaceutical Systems sales, including sales for H1N1 flu vaccinations, while Tech Group sales were flat at $66.3 million.
Read More »
February 16, 2010
Worldwide sales of Singulair were $1.3 billion in the quarter (+12%), and for the year sales were $4.7 billion (+7%).
Read More »
February 10, 2010
Pharmaceutical sales were $9.0 billion (+3%) in 4Q09 and $37.0 billion (+4%) for FY09.
Read More »
February 10, 2010
FY09 revenue from the Biopharmaceuticals business was up 20% to $837.1 million and for 4Q09 was up 28% to $231.9 million.
Read More »
February 9, 2010
Tysabri revenues in the quarter increased 39% to $216 million and Avonex revenues were up 5% to $596 million.
Read More »
316 - 330 of 674 results
